Chugai Pharmaceutical Co Ltd ADR (CHGCY)
Company Info
Highlights
$85.73B
$0.87
29.76
5.00
$315.91B
$227.97B
$158.32B
$15.17 - $31.26
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Chugai Pharmaceutical Co Ltd ADR (CHGCY) returned 18.82% year-to-date (YTD) and 75.55% over the past 12 months. Over the past 10 years, CHGCY delivered an annualized return of 20.30%, outperforming the S&P 500 benchmark at 10.85%.
CHGCY
18.82%
-7.82%
20.69%
75.55%
26.25%
3.70%
20.30%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of CHGCY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.64% | 15.78% | -9.11% | 26.43% | -9.20% | 18.82% | |||||||
| 2024 | -3.46% | 9.59% | -4.96% | -15.76% | -5.20% | 16.80% | 22.70% | 15.32% | -4.18% | -1.08% | -7.68% | -0.14% | 15.96% |
| 2023 | 1.16% | -3.51% | -1.39% | 4.74% | 4.44% | 6.20% | 5.34% | 2.80% | 1.22% | -4.96% | 19.85% | 8.11% | 50.93% |
| 2022 | -0.70% | 2.45% | 2.30% | -10.75% | -8.97% | -5.88% | 9.38% | -6.82% | -3.77% | -7.34% | 11.89% | -0.55% | -19.53% |
| 2021 | -1.94% | -14.46% | -9.13% | -7.65% | 1.28% | 5.09% | -7.65% | 7.06% | -6.22% | 1.28% | -12.98% | 1.23% | -38.02% |
| 2020 | 12.05% | 4.50% | 6.61% | 3.46% | 23.12% | 11.26% | -13.12% | -0.62% | 0.36% | -13.91% | 25.76% | 10.77% | 83.87% |
| 2019 | 1.45% | 15.28% | 1.10% | -8.06% | 5.49% | -1.33% | 9.94% | -0.33% | 8.55% | 8.90% | 3.12% | 7.26% | 62.12% |
| 2018 | 7.59% | -5.14% | -3.64% | 5.39% | 7.17% | -6.85% | -3.43% | 14.66% | 8.71% | -7.86% | 17.64% | -14.30% | 15.67% |
| 2017 | 3.64% | 14.18% | 2.55% | 3.23% | 7.38% | 0.07% | 6.31% | -2.38% | 5.73% | 12.52% | 11.22% | -1.23% | 82.58% |
| 2016 | -14.34% | -1.69% | 4.47% | 13.34% | -1.05% | 2.63% | 3.58% | -15.30% | 15.48% | -7.70% | -14.84% | 1.07% | -18.50% |
| 2015 | 35.19% | 0.22% | 7.99% | -0.20% | -7.52% | 15.19% | 6.89% | 2.04% | -4.13% | -9.69% | 7.65% | 1.88% | 61.10% |
| 2014 | 16.81% | 10.72% | 1.08% | -3.75% | 12.48% | 0.00% | 39.44% | -5.99% | -8.16% | 3.93% | -1.82% | -16.07% | 45.93% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 91, CHGCY is among the top 9% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Chugai Pharmaceutical Co Ltd ADR (CHGCY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Chugai Pharmaceutical Co Ltd ADR provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.27 | $0.29 | $0.33 | $1.68 | $0.22 | $0.13 | $0.10 | $0.08 | $0.08 | $0.93 |
Dividend yield | 0.00% | 0.00% | 1.42% | 2.25% | 2.01% | 6.30% | 1.41% | 1.33% | 1.13% | 1.70% | 1.42% | 22.15% |
Monthly Dividends
The table displays the monthly dividend distributions for Chugai Pharmaceutical Co Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.13 | $0.27 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.29 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.19 | $0.33 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $1.42 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $1.68 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.22 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.13 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.10 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.08 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.08 |
| 2014 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.93 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Chugai Pharmaceutical Co Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Chugai Pharmaceutical Co Ltd ADR was 58.83%, occurring on Nov 4, 2022. Recovery took 613 trading sessions.
The current Chugai Pharmaceutical Co Ltd ADR drawdown is 13.50%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -58.83% | Jan 19, 2021 | 455 | Nov 4, 2022 | 613 | Apr 17, 2025 | 1068 |
| -33.1% | Aug 19, 2014 | 29 | Dec 15, 2014 | 45 | Jun 22, 2015 | 74 |
| -33.07% | Aug 20, 2015 | 197 | Dec 8, 2016 | 96 | Jun 5, 2017 | 293 |
| -28.86% | Jul 8, 2020 | 82 | Oct 30, 2020 | 49 | Jan 12, 2021 | 131 |
| -16.53% | May 6, 2025 | 7 | May 14, 2025 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Chugai Pharmaceutical Co Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Chugai Pharmaceutical Co Ltd ADR, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -1.4%.
Valuation
The Valuation section provides an overview of how Chugai Pharmaceutical Co Ltd ADR is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CHGCY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, CHGCY has a P/E ratio of 29.8. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CHGCY compared to other companies in the Drug Manufacturers - General industry. CHGCY currently has a PEG ratio of 5.0. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CHGCY relative to other companies in the Drug Manufacturers - General industry. Currently, CHGCY has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CHGCY in comparison with other companies in the Drug Manufacturers - General industry. Currently, CHGCY has a P/B value of 6.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |